RDCRC Administrative Unit

$44,231U54FY2011HDNIH

University Of Alabama At Birmingham, Birmingham AL

Investigators

Linked publications & trials

Paper 39679858 Paper 39202466 Paper 38790223 Paper 38775384 Paper 38721759 Paper 38474085 Paper 38438817 Paper 37833681 Paper 37581718 Paper 36993737 Paper 36870948 Paper 36522453 Paper 36372969 Paper 35483386 Paper 35063470 Paper 34979033 Paper 34841387 Paper 34642905 Paper 34595733 Paper 34547934 Paper 34536900 Paper 34530725 Paper 34388423 Paper 34028805 Paper 33517526 Paper 33480039 Paper 33211820 Paper 33170557 Paper 33024833 Paper 32984552 Paper 32792659 Paper 32698758 Paper 32551137 Paper 32472944 Paper 32161522 Paper 31854050 Paper 31684986 Paper 31313283 Paper 31147226 Paper 31090212 Paper 30942555 Paper 30928302 Paper 30826071 Paper 30788845 Paper 30664568 Paper 30649225 Paper 30556641 Paper 30536762 Paper 30217666 Paper 29737008 Paper 29681103 Paper 29657083 Paper 29264392 Paper 28944563 Paper 28838622 Paper 28347601 Paper 28163986 Paper 28132121 Paper 28007990 Paper 27929079 Paper 27828991 Paper 27815692 Paper 27570781 Paper 27491553 Paper 27194034 Paper 27171548 Paper 26995066 Paper 26883647 Paper 26615966 Paper 26332183 Paper 26278631 Paper 26076992 Paper 25914188 Paper 25895911 Paper 25861995 Paper 25801175 Paper 25713300 Paper 25705109 Paper 25355237 Paper 25283752 Paper 25083850 Paper 25071871 Paper 24776956 Paper 24574081 Paper 24515997 Paper 24399845 Paper 24348096 Paper 24200039 Paper 24136956 Paper 24127921 Paper 24050745 Paper 23953953 Paper 23928912 Paper 23696513 Paper 23696494 Paper 23594820 Paper 23433655 Paper 23241593 Paper 23163318 Paper 23035069

Abstract

Alan Percy, MD is the PI for this RDCRC;Arthur Beaudet, MD is the co-Pi;and Jane Lane, RN, BSN is the Project Manager. Dr. Percy will commit 20% effort and Dr. Beaudet 10% effort to their respective roles, in both cases with institutional salary support from DAB and Baylor, respectively. Ms. Lane will commit 50% effort as Project Manager. The organizational chart below provides an overview of the chain of responsibility, the consortium lead investigators and the respective consortium sites for AS, RTT, and PWS, the interaction with and between the patient advocacy groups, and the connection of each site to the DTCC/DMCC.

View original record on NIH RePORTER →